Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)

Emory University Hospital, Atlanta

The Ohio State University Wexner Medical Center, James Cancer Hospital, Columbus

University Hospital of Cleveland, Cleveland

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

The University of Chicago Medical Center, Chicago

The University of Texas MD Anderson Cancer Center, Houston

UC San Diego Moores Cancer Center, La Jolla

Smilow Cancer Hospital at Yale-New Haven, New Haven

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Rutgers Cancer Institute of New Jersey, New Brunswick